Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2008 Aug;10(8):560-74.
doi: 10.1097/gim.0b013e3181809613.

Angiotensin II type 1 receptor polymorphisms and susceptibility to hypertension: a HuGE review

Affiliations
Meta-Analysis

Angiotensin II type 1 receptor polymorphisms and susceptibility to hypertension: a HuGE review

Amy K Mottl et al. Genet Med. 2008 Aug.

Abstract

The angiotensin II type 1 receptor (AGTR1) plays an integral role in blood pressure control, and is implicated in the pathogenesis of hypertension. Polymorphisms within this gene have been extensively studied in association with hypertension; however, findings are conflicting. To clarify these data, we conducted a systematic review of association studies of AGTR1 polymorphisms and hypertension, and performed a meta-analysis of the rs5186 variant. Results show that the currently available literature is too heterogeneous to draw meaningful conclusions. The definition of hypertension and gender composition of individual studies helps to explain this heterogeneity. Although the structure and splicing pattern of AGTR1 would suggest a likely effect of polymorphisms within the promoter region on gene function, few studies have been conducted thus far. In conclusion, there is insufficient evidence that polymorphisms in the AGTR1 gene are risk factors for hypertension. However, most studies are inadequately powered, and larger well-designed studies of haplotypes are warranted.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
A C, Forest plots for dominant, recessive, and additive genetic models of rs5186 polymorphism in association with hypertension, including all studies. (Dotted line represents null value.) Filled OR is the adjusted estimate using meta-bias to estimate results if publication bias were not present. (1A) Dominant Model: *heterogeneity χ2 P = 0.08; τ2 = 0.021; I2 = 34%; Egger’s publication bias P = 0.51.†Heterogeneity χ2 P = 0.09; τ2 = 0.028;I2 = 35%; Egger’s publication bias P = 0.75. (1B) Recessive Model:*heterogeneity χ2 P = 0.08; τ2 0.074; I2 = 34%; Egger’s publication bias P = 0.98.†Heterogeneity χ2 P = 0.68; τ2 = 0.000;I2 = 0%; Egger’s publication bias P = 0.09; Asian summary OR: 0.99 (95%CI: 0.59, 1.68). (1C) Additive Model: *heterogeneity χ2 P = 0.001; τ2 = 0.040;I2 =58%; Egger’s publication bias P = 0.47. †Heterogeneity χ2 P = 0.15; τ2 = 0.020;I2 =28%; Egger’s publication bias P = 0.93; Asian summary OR: 1.07 (0.93, 1.23).

Similar articles

Cited by

References

    1. Laragh J, Pickering TG. Essential hypertension. In: Brenner B, editor. Brenner & Rector’s the kidney. Philadelphia: W.B. Saunders Company; 1991. pp. 1913–1967.
    1. Gasparo M, Bullock G. The AT1 and AT2 angiotensin receptors. In: Oparil S, Webber M, editors. Hypertension: a companion to Brenner & Rector’s the kidney. Philadelphia: W.B. Saunders Company; 2000. pp. 101–110.
    1. Brenner B, Cooper M, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001;345:861–869. - PubMed
    1. Lewis EJ, Hunsicker LG, Clarke WR, et al. Renoprotective effect of the angiotensin receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med. 2001;345:851–860. - PubMed
    1. Guo D, Furuta H, Mizukoshi M, Inagami T. The genomic organization of human angiotensin II type 1 receptor. Biochem Biophys Res Commun. 1994;200:313–319. - PubMed

Substances